Robuta

Sponsor of the Day: Jerkmate
https://www.billiontoone.com/news-media?tag=Media+Coverage News & Media - BillionToOne Find the latest news, media coverage, and press releases on disease detection, prenatal screening, liquid biopsy in relation to BillionToOne. news mediabilliontoone https://www.billiontoone.com/publications Publications - BillionToOne publicationsbilliontoone https://www.billiontoone.com/news-media/billiontoone-to-participate-in-the-44th-annual-j-p-morgan-healthcare-conference BillionToOne to Participate in the 44th Annual J.P. Morgan Healthcare Conference - BillionToOne annual j pmorgan healthcare conferencebilliontooneparticipate44th https://www.ycombinator.com/blog/billiontoone BillionToOne Goes Public — The Startup That Made Genetic Testing Universal | Y Combinator Today, BillionToOne goes public, becoming YC's fourth publicly traded biotech company. More importantly, they have built one of the most important genetic... goes publicgenetic testingbilliontoonestartupmade https://www.ycombinator.com/companies/billiontoone/jobs/9ZwkJry-senior-software-engineer-digital-experiences-prenatal Senior Software Engineer, Digital Experiences (Prenatal) at BillionToOne | Y Combinator Join a team of brilliant, passionate innovators who wake up every day determined to transform healthcare. At BillionToOne, we've built something... senior software engineerdigital experiencesprenatalbilliontoonecombinator https://www.billiontoone.com/news-media/billiontoone-announces-dual-launch-of-unity-expanded-red-blood-cell-and-platelet-fetal-antigen-nipts-extending-its-leadership-in-setting-the-new-standard-in-prenatal-care BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen... red blood cellbilliontoone announcesduallaunchunity https://www.billiontoone.com/news-media/billiontoone-announces-green-journal-publication-that-underscores-the-role-of-cell-free-dna-nipt-for-fetal-red-blood-cell-antigen-genotyping BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT... cell free dnabilliontoone announcesjournal publicationgreenunderscores https://www.billiontoone.com/technology Our Technology - BillionToOne Our genetic testing platform creates diagnostic tools that quantify DNA changes improving non-invasive prenatal screening and liquid biopsy. technologybilliontoone https://www.prnewswire.com/news-releases/billiontoone-announces-medicare-coverage-for-northstar-select-302430353.html BillionToOne Announces Medicare Coverage for Northstar Select® Apr 16, 2025 - /PRNewswire/ -- BillionToOne, a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announced... billiontoone announcesmedicare coveragenorthstar https://www.billiontoone.com/about About - BillionToOne A precision diagnostics company that quantifies biology to create molecular diagnostics focused on prenatal screening and liquid biopsy. billiontoone https://www.billiontoone.com/news-media/billiontoone-appoints-dr-allen-chen-as-vice-president-of-medical-affairs-and-clinical-development-oncology BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development,... appoints drvice presidentmedical affairsclinical developmentbilliontoone https://www.billiontoone.com/news-media/billiontoone-reports-third-quarter-2025-results BillionToOne Reports Third Quarter 2025 Results - BillionToOne reports third quarter2025 resultsbilliontoone https://www.billiontoone.com/careers/open-positions Open Positions - BillionToOne We pride ourselves on hiring the brightest people to work on innovative products. Explore our open positions. open positionsbilliontoone https://www.billiontoone.com/news-media/billiontoone-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-4-2026 BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026 -... report fourth quarterfull year 2025march 4 2026financial resultsbilliontoone https://www.billiontoone.com/news-media/billiontoone-announces-selection-of-northstar-select-r-as-the-new-liquid-biopsy-test-for-lc-scrum-try-clinical-study-at-national-cancer-center-hospital-east BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for... billiontoone announcesnew liquidselectionnorthstarbiopsy https://www.billiontoone.com/news-media/billiontoone-reports-fourth-quarter-and-full-year-2025-results-and-raises-2026-revenue-guidance BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance -... reports fourth quarterfull year 2025raises 2026billiontooneresults https://www.billiontoone.com/news-media/billiontoone-to-report-first-quarter-2026-financial-results-on-may-6-2026 BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026 - BillionToOne report first quarter2026 financial resultsbilliontoonemay https://www.billiontoone.com/about/leadership-board Leadership & Board - BillionToOne The leadership team and board members at BillionToOne believe that health equity and healthcare improvements are achievable. leadership boardbilliontoone https://www.premjiinvest.com/blog/billiontoone-announces-medicare-coverage-for-northstar-select Premji Invest | BillionToOne Announces Medicare Coverage for Northstar Select Premji Invest | US | Perspectives on the industry, our portfolio partners, and more. What we're reading and thinking. premji investbilliontoone announcesmedicare coveragenorthstar select https://www.prweb.com/releases/greenberg-traurig-represents-billiontoone-inc-in-314m-initial-public-offering-302640264.html Greenberg Traurig Represents BillionToOne Inc. in $314M Initial Public Offering Dec 12, 2025 - /PRNewswire-PRWeb/ -- Global law firm Greenberg Traurig, LLP represented BillionToOne Inc., a precision diagnostics company, on regulatory matters in... initial public offeringgreenberg traurigrepresentsbilliontooneinc